<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Kochumon S</submitter><pubmed_abstract>IL-23, a proinflammatory cytokine, plays a role in the development of inflammatory diseases. However, the association between IL-23 expression in adipose tissue (AT) and glycemic changes in obesity remains unclear. This cross-sectional study aimed to examine the relationship of adipose tissue IL-23 (AT-IL-23) expression with other inflammatory mediators within the same compartment and insulin resistance markers fasting blood glucose (FBG) and glycated hemoglobin (HbA1c) in overweight/obese individuals. Fat biopsies were collected from 10 individuals with a body mass index (BMI) &lt; 25kg/m2 and 51 individuals with a BMI > 25kg/m2 and were analyzed for IL-23 and other inflammatory markers using qRT-PCR. Inflammatory markers, including CD16, CD11c, CCR2, CCR5, TNF-α, IL-1β, IL-2, IL-12, CCL8, CCL19, and CXCL9, were positively correlated with IL-23 in the AT-compartment in the obesity context. Notably, AT-IL-23 was correlated positively with FBG, HbA1c, and homeostasis model assessment of insulin resistance (HOMA-IR), while negatively correlating with adiponectin. These findings suggest that AT-IL-23 is associated with metabolic inflammation and insulin resistance in obesity, suggesting it may be of interest for future biomarker studies.</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1608846</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12554591</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adipose tissue IL-23 is associated with fasting blood glucose and HbA1c in overweight/obese individuals.</pubmed_title><pmcid>PMC12554591</pmcid><pubmed_authors>Albeloushi S</pubmed_authors><pubmed_authors>Ahmad R</pubmed_authors><pubmed_authors>Kochumon S</pubmed_authors><pubmed_authors>Alzaid F</pubmed_authors><pubmed_authors>Bahman F</pubmed_authors><pubmed_authors>Al-Mulla F</pubmed_authors><pubmed_authors>Al Madhoun A</pubmed_authors><pubmed_authors>Tuomilehto J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adipose tissue IL-23 is associated with fasting blood glucose and HbA1c in overweight/obese individuals.</name><description>IL-23, a proinflammatory cytokine, plays a role in the development of inflammatory diseases. However, the association between IL-23 expression in adipose tissue (AT) and glycemic changes in obesity remains unclear. This cross-sectional study aimed to examine the relationship of adipose tissue IL-23 (AT-IL-23) expression with other inflammatory mediators within the same compartment and insulin resistance markers fasting blood glucose (FBG) and glycated hemoglobin (HbA1c) in overweight/obese individuals. Fat biopsies were collected from 10 individuals with a body mass index (BMI) &lt; 25kg/m2 and 51 individuals with a BMI > 25kg/m2 and were analyzed for IL-23 and other inflammatory markers using qRT-PCR. Inflammatory markers, including CD16, CD11c, CCR2, CCR5, TNF-α, IL-1β, IL-2, IL-12, CCL8, CCL19, and CXCL9, were positively correlated with IL-23 in the AT-compartment in the obesity context. Notably, AT-IL-23 was correlated positively with FBG, HbA1c, and homeostasis model assessment of insulin resistance (HOMA-IR), while negatively correlating with adiponectin. These findings suggest that AT-IL-23 is associated with metabolic inflammation and insulin resistance in obesity, suggesting it may be of interest for future biomarker studies.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-05T07:48:50.727Z</modification><creation>2026-05-14T03:12:11.867Z</creation></dates><accession>S-EPMC12554591</accession><cross_references><pubmed>41158638</pubmed><doi>10.3389/fendo.2025.1608846</doi></cross_references></HashMap>